Logo image of CELL

PHENOMEX INC (CELL) Stock Price, Quote, News and Overview

NASDAQ:CELL - Nasdaq - US0843101017 - Common Stock - Currency: USD

0.9981  +0 (+0.31%)

After market: 0.999 +0 (+0.09%)

CELL Quote, Performance and Key Statistics

PHENOMEX INC

NASDAQ:CELL (9/29/2023, 8:22:41 PM)

After market: 0.999 +0 (+0.09%)

0.9981

+0 (+0.31%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High1.27
52 Week Low0.38
Market Cap98.79M
Shares98.98M
Float87.41M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)11-06 2023-11-06/amc
IPO07-17 2020-07-17


CELL short term performance overview.The bars show the price performance of CELL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80 100

CELL long term performance overview.The bars show the price performance of CELL in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of CELL is 0.9981 USD. In the past month the price increased by 5.06%.

PHENOMEX INC / CELL Daily stock chart

CELL Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 19.86 164.16B
DHR DANAHER CORP 27.5 146.60B
A AGILENT TECHNOLOGIES INC 22.83 35.02B
IQV IQVIA HOLDINGS INC 14.41 28.16B
MTD METTLER-TOLEDO INTERNATIONAL 30.25 25.43B
WAT WATERS CORP 29.63 21.00B
WST WEST PHARMACEUTICAL SERVICES 34.21 16.32B
ILMN ILLUMINA INC 29.8 15.71B
RVTY REVVITY INC 20.59 11.96B
ICLR ICON PLC 10.97 11.96B
QGEN QIAGEN N.V. 20.93 10.42B
TEM TEMPUS AI INC N/A 9.85B

About CELL

Company Profile

CELL logo image PhenomeX, Inc. is a biology company that engages in the study of cells. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health. The firm enables scientists to reveal insights into cell function and obtain a full view of the behavior of each cell. Its specific suite of proven tools and services offers unparalleled resolution and speed the insights that are key to advancing discoveries that can completely improve the prevention and treatment of disease. The Company’s platforms are used by researchers across the globe, including various global pharmaceutical companies and approximately 85% of United States cancer centers.

Company Info

PHENOMEX INC

5858 Horton Street, Suite 320

Emeryville CALIFORNIA US

Employees: 285

CELL Company Website

Phone: 15108582855.0

PHENOMEX INC / CELL FAQ

What is the stock price of PHENOMEX INC today?

The current stock price of CELL is 0.9981 USD. The price increased by 0.31% in the last trading session.


What is the ticker symbol for PHENOMEX INC stock?

The exchange symbol of PHENOMEX INC is CELL and it is listed on the Nasdaq exchange.


On which exchange is CELL stock listed?

CELL stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for PHENOMEX INC stock?

11 analysts have analysed CELL and the average price target is 1.53 USD. This implies a price increase of 53.29% is expected in the next year compared to the current price of 0.9981. Check the PHENOMEX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PHENOMEX INC worth?

PHENOMEX INC (CELL) has a market capitalization of 98.79M USD. This makes CELL a Micro Cap stock.


How many employees does PHENOMEX INC have?

PHENOMEX INC (CELL) currently has 285 employees.


What are the support and resistance levels for PHENOMEX INC (CELL) stock?

PHENOMEX INC (CELL) has a support level at 0.99 and a resistance level at 1.01. Check the full technical report for a detailed analysis of CELL support and resistance levels.


Is PHENOMEX INC (CELL) expected to grow?

The Revenue of PHENOMEX INC (CELL) is expected to decline by -10.41% in the next year. Check the estimates tab for more information on the CELL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PHENOMEX INC (CELL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PHENOMEX INC (CELL) stock pay dividends?

CELL does not pay a dividend.


When does PHENOMEX INC (CELL) report earnings?

PHENOMEX INC (CELL) will report earnings on 2023-11-06, after the market close.


What is the Price/Earnings (PE) ratio of PHENOMEX INC (CELL)?

PHENOMEX INC (CELL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.38).


CELL Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to CELL.


Chartmill TA Rating
Chartmill Setup Rating

CELL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CELL. While CELL seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CELL Financial Highlights

Over the last trailing twelve months CELL reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS decreased by -9.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -69.85%
ROE -111.9%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%10.53%
Sales Q2Q%-26.58%
EPS 1Y (TTM)-9.52%
Revenue 1Y (TTM)-17.32%

CELL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 51% to CELL. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 17.97% and a revenue growth -10.41% for CELL


Ownership
Inst OwnersN/A
Ins Owners0.13%
Short Float %N/A
Short RatioN/A
Analysts
Analysts50.91
Price Target1.53 (53.29%)
EPS Next Y17.97%
Revenue Next Year-10.41%